ProgenyHealth Taps Industry Titans to Reshape Maternal-Infant Care

PLYMOUTH MEETING, Pa. – April 29, 2026 – ProgenyHealth, a specialized tech-enabled company focused on maternal and infant health, has announced a significant bolstering of its leadership, appointing three highly experienced executives to its board and C-suite. The move signals an aggressive strategy to scale its impact on maternity and NICU care management at a time when the nation is grappling with a persistent maternal health crisis.

Paul Diaz, a managing partner at healthcare investment firm Cressey & Company, joins the Board of Managers. Mark Sprague, a seasoned financial executive and actuary, has been named Chief Financial Officer. Tom Lundquist, MD, a physician executive with deep experience in clinical leadership, has been appointed Chief Medical Officer. These strategic hires are poised to accelerate the company's mission to improve outcomes for mothers and infants across the country.

A Strategic Infusion of Top-Tier Talent

The caliber of the new appointees speaks volumes about ProgenyHealth's ambitions. Each leader brings a distinct and complementary skill set honed over decades at the highest levels of the healthcare industry.

Paul Diaz brings formidable experience in large-scale growth and corporate strategy to the board. As a managing partner at Cressey & Company, a private equity firm dedicated to healthcare, his appointment underscores a commitment to strategic expansion. Diaz's previous tenures as President and CEO of both Kindred Healthcare, a former Fortune 500 company, and Myriad Genetics, a leader in genetic testing, demonstrate a track record of steering complex healthcare organizations through transformative periods. His recognition by Modern Healthcare as one of the "100 Most Influential People" and "top 25 Minority Executives in Healthcare" highlights his significant influence and expertise in the sector.

Taking the financial helm is Mark Sprague, whose designation as a Fellow of the Society of Actuaries (FSA) provides ProgenyHealth with a rare depth of expertise in healthcare economics and risk management. With over 25 years in financial leadership, including roles as CFO for Healthmap Solutions and Magellan's Healthcare division, Sprague is adept at navigating the intricate financial landscape of healthcare services. His experience at Aetna International further broadens his perspective, equipping him to drive the financial strategy needed to support sustainable growth and enhance the company's value proposition in a competitive market.

On the clinical front, the appointment of Dr. Tom Lundquist as Chief Medical Officer brings profound medical and operational leadership. An alumnus of The Johns Hopkins University School of Medicine, Dr. Lundquist has spent nearly 30 years in senior executive roles across diverse sectors, including tenures as CMO for major players like Highmark Health and Sentara Health Plans. His direct experience leading medical management programs for large care delivery systems and managed care organizations is critical for a company whose core mission is delivering superior clinical performance and improving health outcomes for the most vulnerable patients.

Confronting a National Health Crisis

The leadership reinforcement comes at a critical juncture for maternal and infant health in the United States. The nation continues to report alarmingly high rates of maternal mortality and morbidity compared to other developed countries, with stark racial and ethnic disparities persisting. Black and American Indian/Alaska Native women face significantly higher risks, a challenge that demands targeted and effective interventions.

ProgenyHealth has carved out a unique position by focusing on the most complex and costly aspects of this crisis: high-risk pregnancies and the resulting NICU admissions for premature and medically complex infants. With over two decades of experience, the company's model is built on a foundation of specialized clinical support provided by board-certified physicians, nurses, and social workers. This approach directly addresses the factors that contribute to poor outcomes and high healthcare costs.

Dr. Lundquist's appointment, in particular, signals a doubling down on clinical excellence. His expertise is expected to enhance the company's evidence-based care management programs, ensuring that the latest clinical insights and best practices are integrated into the support provided to families. This focus on quality is essential for a company aiming to not just manage care but to fundamentally change its trajectory.

Fortifying a Niche in a Dynamic Market

The digital health landscape for women's health is increasingly crowded, with companies like Babyscripts, Ovia Health, and Carrot Fertility offering a range of services from general pregnancy tracking to fertility benefits. However, ProgenyHealth's deep specialization in the high-acuity NICU and maternity care management space remains a key differentiator. The new leadership team is well-equipped to fortify and expand this niche.

Paul Diaz's involvement through Cressey & Company suggests a strategic focus on growth, potentially through market expansion, new partnerships with health plans, or even strategic acquisitions. Mark Sprague's financial and actuarial acumen will be instrumental in developing innovative, value-based models that align the company's financial success with improved patient outcomes—a compelling proposition for payers and employers seeking to control costs while enhancing care quality.

In a statement, CEO Susan Torroella emphasized this strategic direction. "As ProgenyHealth continues our goal to improve maternal and infant outcomes nationwide, we're continually investing in talent that can help us scale that impact," she said. "Paul, Mark and Tom bring deep expertise across clinical care, financial strategy and healthcare operations — exactly what we need to accelerate growth and deliver better outcomes for the families we serve."

This sentiment reflects a clear strategy: leveraging deep industry experience to navigate industry challenges and solidify market leadership. The appointments are a testament to the company's vision and its ability to attract top-tier talent in a competitive environment.

Scaling a Tech-Enabled Vision for Better Outcomes

At the heart of ProgenyHealth's model is its "tech-enabled" approach, which uses technology to empower its clinical teams and engage families more effectively. The new leadership is expected to champion the evolution of this platform, integrating more advanced data analytics and digital tools to identify at-risk mothers and infants earlier and deliver more personalized interventions.

With a team that now combines high-level strategic, financial, and clinical expertise, ProgenyHealth is strongly positioned to enhance its service offerings and expand its reach. The combined experience of Diaz, Sprague, and Lundquist creates a formidable leadership core capable of navigating the complex regulatory, financial, and clinical challenges of the U.S. healthcare system.

As Torroella noted, the company is focused on its mission to "change the trajectory of maternal and infant health one family at a time." With this powerful new leadership team in place, ProgenyHealth has significantly strengthened its capacity to deliver on that promise on a national scale.